Who We Are

The National Kidney Foundation, Inc., a major voluntary health organization, seeks to prevent kidney and urinary tract diseases, improve the health and well-being of individuals and families affected by these diseases, and increase the availability of all organs for transplantation.

Our Goals

Background

The NKF Serving Greater New York is a division of the National Kidney Foundation. Our service territory includes the New York metropolitan area including all five boroughs, Westchester, the Hudson Valley, and middle and northern New Jersey. The NKF mission is to prevent kidney and urinary tract diseases, improve the health and well-being of individuals and families affected by these diseases, and increase the availability of all organs for transplantation.

Staff

Ingrid Montecino
Division President
ingridm@kidney.org
(212) 889-2210 x194

Ellen Yoshiuchi
Program Director
elleny@kidney.org
(212) 889-2210 x228

Melissa Saul
Director of Development
melissas@kidney.org
(212) 889-2210 x221

Katherine Gallante
Manager of Community Outreach and Education
katherineg@kidney.org
(212) 889-2210 x251

Lindsay Gilman
Community Development Manager
lindsayg@kidney.org
(212) 889-2210 x203

Ashante Wilson
Donor Records Manager
ashantew@kidney.org
(212) 889-2210 x296

Elizabeth Siviski
Community Development Manager
elizabeth.siviski@kidney.org
(212) 889-2210 x253

Sujeiry Corniel
Education Assistant
sujeiry.corniel@kidney.org
(212) 889-2210 x326

Emily Keber
Administrative Assistant, Development
Emily.keber@kidney.org
(212) 889-2210 x297

Board of Directors

Chairman - William G. Dessoffy, CFA
Regional Managing Director of the New York Region
First Republic Bank

Vice-Chairman, Steven A. Moll
VP and Associate General Counsel - Employment and Labor
Thomson Reuters

Secretary - Cathy Gold
Manager, Corporate Governance, PepsiCo, Inc

Treasurer - Jose Pincay-Delgado
Executive Vice President & CFO
Alex Donner Entertainment Corp.

Joseph D. Abruzzese
President, Advertising Sales
Discovery Communications

Michael Bekas, CPA
Partner, Marks Paneth and Shron LLP

Jeanne Fedoryk
VP Global HR Transformation
Johnson & Johnson

Howard B. Fields, CPA
Assistant Vice President Markets Group
Federal Reserve Bank of New York

Ira S. Meisels, M.D.
Medical Director Dialysis
St. Luke's Roosevelt Hospital Center

Stephen J. Nicholas, MD
Director, Nicholas Institute of Sports Medicine and Athletic Trauma

Lon Rubackin
Managing Partner
GFI Retail Services Group

Keri-Lynne Shaw
Performance Management Manager, BMW of North America

Richard C. Stockinger
Chief Executive Officer, Benihana Inc.

John Wang, M.D.
Director, Jack J. Dreyfus Clinic, The Rogosin Institute

Barry Zeller
Executive Vice President, Cushman & Wakefield

Medical Advisory Board

Howard Trachtman, MD (#1)
Chief, Division of Pediatric Nephrology
Schneider Children's Hospital, New Hyde Park, NY

Khalid M. H. Butt, MD (#2)
Chief, Kidney Transplantation
Westchester Medical Center, Valhalla, NY

Leonard Meggs, MD (#3)
Chief, Division of Nephrology & Hypertension
University of Medicine & Dentistry of New Jersey Newark, NJ

Steven Fishbane, MD (#4)
Chief, Division of Nephrology and Hypertension
Winthrop University Hospital, Mineola, NY

Leonard Stern, MD (#5)
Medical Director, Columbia University Dialysis Center, New York, NY

John Wang, MD (#6)
Director, Jack J. Dreyfus Clinic
The Rogosin Institute, New York, NY

Ira S. Meisels, MD (#7)
Medical Director of Dialysis
St. Luke's – Roosevelt Hospital Center, New York, NY

Maria V. De Vita, MD *
Associate Director
Sol Goldman Renal Therapy Center, New York, NY

Mariana Markell, MD *
Associate Professor of Medicine
SUNY Downstate Medical Center, Brooklyn, NY

Jonathan A. Winston, M.D.*
Associate Professor of Medicine
Division of Nephrology
Mt. Sinai Medical Center, New York, NY 10029

Thomas H. Hostetter, MD *
Chief, Division of Nephrology
Montefiore Medical Center, Bronx, NY

*not pictured

Our Founder

On November 15, 1950, Mr. and Mrs. Harry DeBold called the first meeting of the Committee for Nephrosis Research. Several months earlier, Mrs. DeBold’s infant son was stricken with nephrosis, a condition of which little was known and for which little could be done. Her determination not to succumb to the grim reality of her son’s disease and her affluence and wealth were important elements which led to the formation of the inaugural lay group destined to becomeThe National Kidney Foundation. The Ada DeBold Society was created to help ensure the philanthropic future of the NKF in honor of Mrs. Ada U. DeBold.

By sharing their financial resources and publicly expressing their support, members of The Ada DeBold Society address NKF’s mission to prevent kidney and urinary tract diseases, improve the health and well-being of individuals and families affected by these diseases, and increase the availability of all organs for transplantation. This framework of support helps the NKF plan for the present and look to the future. More information about The Ada DeBold Society.